MAPT and Alzheimer disease: Subtype 3 was also significantly enriched for African Americans and males, who exhibited lower immunoassay CSF tau levels in AD cases, which is consistent with the sex and race-based associations observed for M1 (BBB/plasma) and lower M2 (synaptic) for these individuals (Figs. 1 and 2).